Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ImmunoGen Inc.

www.immunogen.com

Latest From ImmunoGen Inc.

Finance Watch: Gene Therapy, Targeted Oncology Driving IPOs Despite Biopharma Stock Shakiness

Public Company Edition: Jefferies report notes robust IPO market, but SVB Leerink predicts a financing slowdown. Also, Mirati raises cash for KRAS programs after Amgen's ASCO data and a strategic shift results in job cuts at ImmunoGen.

Financing Deals

ImmunoGen Regroups After FORWARD Setback, Looks To New Ovarian Cancer Phase III

US FDA dashes hopes for accelerated approval of mirvetuximab soravtansine based on subgroup data, but will work with ImmunoGen to design a new trial focused on highly FRα-positive patients.

Cancer Drug Approval Standards

ImmunoGen Needs Another Phase III For Its ADC In Ovarian Cancer

The biotech’s hopes for an accelerated approval on subgroup data were dashed by the US FDA, but it will work with the agency to design a Phase III focused on highly FRα-positive patients.

Clinical Trials Drug Approval Standards

Asia Deal Watch: Takeda On A Deal Spree

Takeda has inked three deals in recent days: a cancer antibody-drug conjugate partnership, a PI3K out-license and a nanomedicine drug-delivery pact. AstraZeneca gains expanded rights to Kyowa Hakko Kirin’s Fasenra.

Asia Pacific Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ImmunoGen Inc.
  • Senior Management
  • Mark J Enyedy, Pres. & CEO
    David B Johnston, EVP, CFO
    Richard J Gregory, PhD, EVP, CSO
    Blaine McKee, PhD, VP, CBO
    Anna Berkenbilt, MD, VP, CMO
  • Contact Info
  • ImmunoGen Inc.
    Phone: (781) 895-0600
    830 Winter St.
    Waltham, MA 02451-1477
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register